These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 302726

  • 1. Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor.
    Claassen V, Davies JE, Hertting G, Placheta P.
    Br J Pharmacol; 1977 Aug; 60(4):505-16. PubMed ID: 302726
    [Abstract] [Full Text] [Related]

  • 2. Du 24565, a quipazine derivative, a potent selective serotonin uptake inhibitor.
    Vaatstra WJ, Deiman-Van Aalst WM, Eigeman L.
    Eur J Pharmacol; 1981 Mar 12; 70(2):195-202. PubMed ID: 6973481
    [Abstract] [Full Text] [Related]

  • 3. Pharmacology in vivo of the phenylindan derivative, Lu 19-005, a new potent inhibitor of dopamine, noradrenaline and 5-hydroxytryptamine uptake in rat brain.
    Arnt J, Christensen AV, Hyttel J.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Apr 12; 329(2):101-7. PubMed ID: 2409454
    [Abstract] [Full Text] [Related]

  • 4. The pharmacology of zimelidine: a 5-HT selective reuptake inhibitor.
    Ogren SO, Ross SB, Hall H, Holm AC, Renyi AL.
    Acta Psychiatr Scand Suppl; 1981 Apr 12; 290():127-51. PubMed ID: 6452789
    [Abstract] [Full Text] [Related]

  • 5. Ifoxetine, a compound with atypical effects on serotonin uptake.
    Waldmeier PC, Maître L, Baumann PA, Hauser K, Bischoff S, Bittiger H, Paioni R.
    Eur J Pharmacol; 1986 Oct 14; 130(1-2):1-10. PubMed ID: 2877890
    [Abstract] [Full Text] [Related]

  • 6. Review of the animal pharmacology and pharmacokinetics of fluvoxamine.
    Claassen V.
    Br J Clin Pharmacol; 1983 Oct 14; 15 Suppl 3(Suppl 3):349S-355S. PubMed ID: 6407497
    [Abstract] [Full Text] [Related]

  • 7. Effects of tandamine and pirandamine, new potential antidepressants, on the brain uptake of norepinephrine and 5-hydroxytryptamine and related activities.
    Pugsley T, Lippmann W.
    Psychopharmacology (Berl); 1976 May 05; 47(1):33-41. PubMed ID: 1085452
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological properties of 403U76, a new chemical class of 5-hydroxytryptamine- and noradrenaline-reuptake inhibitor.
    Ferris RM, Brieaddy L, Mehta N, Hollingsworth E, Rigdon G, Wang C, Soroko F, Wastila W, Cooper B.
    J Pharm Pharmacol; 1995 Sep 05; 47(9):775-81. PubMed ID: 8583392
    [Abstract] [Full Text] [Related]

  • 9. Fluvoxamine, a new antidepressant drug, fails to show antiserotonin activity.
    Maj J, Rogóz Z, Skuza G.
    Eur J Pharmacol; 1982 Jul 09; 81(2):287-92. PubMed ID: 6811291
    [Abstract] [Full Text] [Related]

  • 10. Pharmacology of a new phthalane (Lu 10-171), with specific 5-HT uptake inhibiting properties.
    Christensen AV, Fjalland B, Pedersen V, Danneskiold-Samsoe P, Svendsen O.
    Eur J Pharmacol; 1977 Jan 21; 41(2):153-62. PubMed ID: 12988
    [Abstract] [Full Text] [Related]

  • 11. Effects of viloxazine, an antidepressant agent, on biogenic amine uptake mechanisms and related activities.
    Lippman W, Pugsley TA.
    Can J Physiol Pharmacol; 1976 Aug 21; 54(4):494-509. PubMed ID: 974878
    [Abstract] [Full Text] [Related]

  • 12. Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: Lu 10-171.
    Hyttel J.
    Psychopharmacology (Berl); 1977 Mar 16; 51(3):225-33. PubMed ID: 403537
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological and ultrastructural maturation of serotonergic synapses during ontogeny.
    Tissari AH.
    Med Biol; 1975 Feb 16; 53(1):1-14. PubMed ID: 1095838
    [Abstract] [Full Text] [Related]

  • 14. Neuroendocrine studies with fluvoxamine: animal data.
    Cella S, Penalva A, Locatelli V, Novelli A, Cocchi D, Müller EE.
    Br J Clin Pharmacol; 1983 Feb 16; 15 Suppl 3(Suppl 3):357S-364S. PubMed ID: 6134546
    [Abstract] [Full Text] [Related]

  • 15. Effect of lofepramine and other antidepressants on the uptake of 5-hydroxytryptamine and noradrenaline into rat brain monoaminergic neurons.
    Segawa T, Nomura Y, Tanaka A, Murakami H.
    J Pharm Pharmacol; 1977 Mar 16; 29(3):139-42. PubMed ID: 15076
    [Abstract] [Full Text] [Related]

  • 16. Drug-induced release of biogenic amines from synaptosomes and blood platelets of guinea-pigs.
    Peyer M, Pletscher A, Affolter H.
    Neuropharmacology; 1982 Sep 16; 21(9):831-8. PubMed ID: 6216418
    [Abstract] [Full Text] [Related]

  • 17. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.
    Leysen JE, Eens A, Gommeren W, van Gompel P, Wynants J, Janssen PA.
    J Pharmacol Exp Ther; 1988 Jan 16; 244(1):310-21. PubMed ID: 3336007
    [Abstract] [Full Text] [Related]

  • 18. Pharmacology of lortalamine, a new potent non-tricyclic antidepressant.
    Depin JC, Betbeder-Matibet A, Bonhomme Y, Muller AJ, Berthelon JJ.
    Arzneimittelforschung; 1985 Jan 16; 35(11):1655-62. PubMed ID: 4091869
    [Abstract] [Full Text] [Related]

  • 19. Fluvoxamine influences serotonergic system in the brain: neurochemical evidence.
    Lapierre YD, Rastogi RB, Singhal RL.
    Neuropsychobiology; 1983 Jan 16; 10(4):213-6. PubMed ID: 6427651
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.